Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2018
The 8th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2018 in Geneva, Switzerland
Presentation Date(s):- Apr 11 - 14, 2018
- Total Presentations: 407
-
+
Poster Display session (Thursday)
- Type: Poster Display session
- Presentations: 0
- Coordinates: 4/12/2018, 12:30 - 13:00, Hall 1
-
+
Industry Satellite Symposium 3
- Type: Industry Satellite Symposium
- Presentations: 1
- Coordinates: 4/12/2018, 13:00 - 14:00, Room A
-
+
Presentation
13:00 - 13:20
- Abstract
No abstract available for this presentation
-
+
Keynote lecture
- Type: Keynote Lecture
- Presentations: 1
- Moderators:M. Garassino
- Coordinates: 4/12/2018, 14:10 - 14:40, Room B
-
+
Molecular and immuno landscaping in lung cancer
14:10 - 14:40 | Presenter: M. Sibilia
- Abstract
No abstract available for this presentation
-
+
Relevant biomarkers for the use of immune checkpoints
- Type: Educational session
- Presentations: 5
- Moderators:I. Wistuba
- Coordinates: 4/12/2018, 14:45 - 16:15, Room C
-
+
Update on PD-L1 and other immunohistochemistry biomarkers
14:45 - 15:00 | Presenter: F. Hirsch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Can we use cytology specimens for PD-L1 testing?
15:00 - 15:15 | Presenter: L. Bubendorf
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Comprehensive profiling of the immune microenvironment
15:15 - 15:30 | Presenter: I. Wistuba
- Abstract
No abstract available for this presentation
-
+
Molecular profiling
15:30 - 15:45 | Presenter: R. Büttner
- Abstract
No abstract available for this presentation
-
+
Q&A
15:45 - 16:15
- Abstract
No abstract available for this presentation
-
+
Limitations and advances of thoracic radiotherapy
- Type: Proffered Paper session
- Presentations: 4
- Moderators:C. Le Pechoux
- Coordinates: 4/12/2018, 15:00 - 16:00, Room B
-
+
110O - High-dose radiation therapy based on normal tissue constraints with concurrent chemotherapy improves survival of patients with unresectable stage III non-small cell lung cancer
15:00 - 15:15 | Presenter: B. Li
- Abstract
Loading... -
+
111O - Impact of cardiac doses on survival of non-small cell lung cancer (NSCLC) patients following radical accelerated radiotherapy
15:15 - 15:30 | Presenter: M. Hatton
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
131O - Radiotherapy improves the survival of patients with stage IV non-small cell lung cancer: A propensity matched analysis of surveillance, epidemiology, and end results database
15:30 - 15:45 | Presenter: R. Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 110O, 111O and 131O
15:45 - 16:00 | Presenter: C. Le Pechoux
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
T790M: Liquid biopsy or histological samples?
- Type: Controversy session
- Presentations: 4
- Moderators:M. Denis
- Coordinates: 4/12/2018, 15:00 - 16:00, Room A
-
+
Introduction and first vote
15:00 - 15:10 | Presenter: M. Denis
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Liquid biopsy
15:10 - 15:30 | Presenter: N. Reguart
- Abstract
No abstract available for this presentation
-
+
Histological samples
15:30 - 15:50 | Presenter: E. Rouleau
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Second vote and conclusions
15:50 - 16:00 | Presenter: M. Denis
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Coffee break
- Type: Coffee break
- Presentations: 0
- Coordinates: 4/12/2018, 16:15 - 16:45, Hall 1
-
+
How can we optimise our organisation to deliver precision oncology?
- Type: Educational session
- Presentations: 5
- Moderators:P. Garrido Lopez
- Coordinates: 4/12/2018, 16:45 - 18:15, Room A
-
+
Organisational models for biomarkers testing
16:45 - 17:05 | Presenter: S. Popat
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Access to personalised medicine
17:05 - 17:25 | Presenter: P. Garrido Lopez
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
The pathologist’s point of view
17:25 - 17:45 | Presenter: F. Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
The patient’s point of view
17:45 - 18:05 | Presenter: S. Novello
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Q&A
18:05 - 18:15
- Abstract
No abstract available for this presentation
-
+
Optimizing targeted therapy in lung cancer
- Type: Poster Discussion session
- Presentations: 9
- Moderators:F. Cappuzzo
- Coordinates: 4/12/2018, 16:45 - 17:45, Room W
-
+
3PD - Co-targeting PIM1 or Src to overcome the limits of single MET inhibition
16:45 - 16:45 | Presenter: I. Attili
- Abstract
Loading... -
+
51PD - Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites
16:45 - 16:45 | Presenter: F. Morgillo
- Abstract
Loading... -
+
132PD - Plasma concentrations of pemetrexed to predict clinical outcomes in patients with advanced NSCLC
16:45 - 16:45 | Presenter: S. Visser
- Abstract
Loading... -
+
Invited Discussant 3PD, 51PD and 132PD
16:45 - 17:00 | Presenter: F. Cappuzzo
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:00 - 17:15
- Abstract
No abstract available for this presentation
-
+
52PD - EGFR clonality and tumor mutation burden (TMB) analysis based on circulating tumor DNA (ctDNA) sequencing in advanced non-small cell lung cancer (NSCLC)
17:15 - 17:15 | Presenter: X. Ai
- Abstract
Loading... -
+
133PD - Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) for non-small cell lung cancer (NSCLC): A systematic review and meta-analysis
17:15 - 17:15 | Presenter: J. Raphael
- Abstract
Loading... -
+
Invited Discussant 52PD and 133PD
17:15 - 17:30 | Presenter: N. Peled
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discussion
17:30 - 17:45
- Abstract
No abstract available for this presentation
-
+
PD-L1 expression and tumor microenvironment in advanced lung cancer
- Type: Proffered Paper session
- Presentations: 6
- Moderators:G. Scagliotti
- Coordinates: 4/12/2018, 16:45 - 18:15, Room B
-
+
78O - Immune microenvironment of small cell lung cancer (SCLC): Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumor infiltrating lymphocytes
16:45 - 17:00 | Presenter: A. Pavan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
130O - Real-world prevalence of PD-L1 expression in locally advanced or metastatic non-small cell lung cancer (NSCLC): The global, multicentre EXPRESS study
17:00 - 17:15 | Presenter: M. Dietel
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 78O and 130O
17:15 - 17:30 | Presenter: K. Kerr
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
1O - Integration of tissue and circulating parameters identifies a favorable immune profile in NSCLC patients treated with nivolumab
17:30 - 17:45 | Presenter: G. Mazzaschi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
2O - MET activation in lung cancer up-regulates PD-L1 expression independently of JAK-STAT pathway, promoting an immunosuppressive phenotype
17:45 - 18:00 | Presenter: M. Saigí
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Invited Discussant 1O and 2O
18:00 - 18:15 | Presenter: F. Skoulidis
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
first
prev
